NCT06651671 is a NA clinical trial of Myofascial release in Myofascial Dysfunction, sponsored by Rowan University.

Who is sponsoring NCT06651671?

NCT06651671 is sponsored by Rowan University.

What drugs are being tested in NCT06651671?

Interventions in NCT06651671: Myofascial release, Sham (No Treatment).

What condition does NCT06651671 study?

NCT06651671 studies Myofascial Dysfunction, Myofascial Release.

Is NCT06651671 still recruiting?

NCT06651671 is currently completed. Last updated 22 October 2024.

Last reviewed 2024-10-22 · How we verify

NCT06651671

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Tissue Changes Following Thoracic Myofascial Release

Completed NA Last updated 22 October 2024

What this trial tests

NA trial testing Myofascial release in Myofascial Dysfunction in 60 participants. Completed in 31 July 2023.

Timeline

30 March 2023

Primary endpoint
30 July 2023

31 July 2023

Quick facts

Lead sponsor	Rowan University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	30 March 2023
Primary completion	30 July 2023
Estimated completion	31 July 2023
Sites	1 location across United States

Drugs / interventions tested

Myofascial release
Sham (No Treatment) — full drug profile →

Conditions studied

Myofascial Dysfunction — all drugs for Myofascial Dysfunction →
Myofascial Release — all drugs for Myofascial Release →

Sponsor

Rowan University

Who can join

Adults 18 to 35, any sex, with Myofascial Dysfunction or Myofascial Release. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Brief Summary: The goal of this clinical trial is to determine the efficacy of myofascial release in altering the parameters of muscle tone, stiffness, and viscoelasticity in young adults. The main questions it aims to answer are: What is the efficacy of myofascial release in altering muscle tone, stiffness, and viscoelasticity? What is the efficacy of light hands-on sham as a control? Are there differences in these parameters between men and women? What is the reliability of MyotonPro use in young adults? Researchers will randomly allocate and compare the treatment group, which receives osteopathic manipulative medicine (OMM) in the form of 30 seconds of indirect myofascial release followed by 30 seconds of direct myofascial release, to the control group, which receives 1 minute of light hands-on traps placebo, to see if there are differences in muscle tone, stiffness, and viscoelasticity.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Myofascial release

Trials testing the same drug.

NCT07249684 — Myofascial Release And Static Stretching Along With Nighttime Bracing · NA · completed
NCT07125404 — Low-Level Laser Auriculotherapy in the Treatment of Myogenic Temporomandibular Disorders and Anxiety · NA · not yet recruiting
NCT07117019 — Effect of Myofascial Release Combined With Acupressure on BL23 On Chronic Perineal Pain · NA · completed
NCT07130747 — Effect of Myofascial Release Versus Deep Friction Massage on Abdominal Recovery and Scar After Cesarean Section · NA · recruiting
NCT06820827 — Effect of High Power Pain Threshold Ultrasound on Postnatal Sacroiliac Joint Pain · NA · not yet recruiting

Other Rowan University trials

Trials by the same sponsor.

NCT07213388 — Immersive Virtual Reality vs Treadmill Exercise Project · NA · completed
NCT06235463 — Pedal Pump and Leg Lymphedema · NA · recruiting
NCT06350604 — Project WHADE: A Partner-Based Physical Activity Program for Women · NA · completed
NCT07256808 — Medial Tibial Stress Syndrome Prevention · NA · completed
NCT05224154 — Re-Connect Application for Smoking Cessation · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06651671 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Rowan University
Last refreshed: 22 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06651671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing